|
Controversies in Hematology
Citations 1-10 of 16 total displayed.
|
Most recent content
(15 Nov 2003):
|
Transplantation for multiple myeloma: who, when, how often?
- Joan Bladé, David H. Vesole, and Morie Gertz
Blood 2003; 102: 3469-3477.
[Full text]
[PDF]
|
Past content
(since Jul 1998):
|
The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis
- Ernest Beutler
Blood 2003; 101: 3347-3350.
[Full text]
[PDF]
Clinical consequences of iron overload in hemochromatosis homozygotes
- Richard S. Ajioka and James P. Kushner
Blood 2003; 101: 3351-3353.
[Full text]
[PDF]
Rebuttal to Ajioka and Kushner
- Ernest Beutler
Blood 2003; 101: 3354-3357.
[Full text]
[PDF]
Rebuttal to Beutler
- Richard S. Ajioka and James P. Kushner
Blood 2003; 101: 3358.
[Full text]
[PDF]
Specific inhibition of bcr-abl gene expression by small interfering RNA
- Michaela Scherr, Karin Battmer, Thomas Winkler, Olaf Heidenreich, Arnold Ganser, and Matthias Eder
Blood 2003; 101: 1566-1569.
[Abstract]
[Full text]
[PDF]
Discrepancies between genotype and phenotype in hematology: an important frontier
- Ernest Beutler
Blood 2001; 98: 2597-2602.
[Abstract]
[Full text]
[PDF]
HHV-8 Is Present in Multiple Myeloma Patients
- James R. Berenson and Robert A. Vescio
Blood 1999; 93: 3157-3159.
[Full text]
[PDF]
Kaposi's Sarcoma-Associated Herpesvirus and Multiple Myeloma: Lack of Criteria for Causality
- Karin Tarte, Yuan Chang, and Bernard Klein
Blood 1999; 93: 3159-3163.
[Full text]
[PDF]
Rebuttal to Tarte, Chang, and Klein
-
Blood 1999; 93: 3163-3164.
[Full text]
[PDF]
|
|
